Toxoplasmic encephalitis in AIDS.
Dannemann
B R
BR
Stanford University School of Medicine.
Remington
J S
JS
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D015215:Zidovudine / Q000627:therapeutic use
D000913:Antibodies, Protozoan; D013449:Sulfonamides; D015215:Zidovudine; D011739:Pyrimethamine